Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose-ranging study. Alba M, Yee J, Frustaci ME, Samtani MN, Fleck P. Clinical obesity. 2021; 11(2): e12432
